Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
NVO Stock Up 3% as UBS Upgrades Company Rating From Neutral to Buy
11:26am, Thursday, 09'th Jan 2025
Novo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand recognition of Ozempic and Wegovy.
Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'
01:30pm, Wednesday, 08'th Jan 2025
Novo Nordisk's (NVO) U.S.-listed and domestic shares rose Wednesday after analysts from UBS Research upgraded the Danish drugmaker's stock to "buy" from "neutral," calling the recent sell-off of the s
How Trump's Greenland Plan Could Hit Ozempic, Legos and Hearing Aids
12:24pm, Wednesday, 08'th Jan 2025
Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular medicines.
How a new Denmark tariff could impact Novo Nordisk
10:54am, Wednesday, 08'th Jan 2025
President-elect Donald Trump threatened higher tariffs against longtime ally Denmark over its ownership of Greenland as a Danish territory; Trump even floated the idea of the US purchasing Greenland.
Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs
10:01am, Wednesday, 08'th Jan 2025
Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and arti
Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals
09:45am, Wednesday, 08'th Jan 2025
On Wednesday, Novo Nordisk A/S NVO and Valo Health, Inc. entered into an expanded agreement to discover and develop novel treatments for obesity, type 2 diabetes, and cardiovascular disease.
This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly
09:45am, Wednesday, 08'th Jan 2025
Eli Lilly (LLY -0.27%) and Novo Nordisk (NVO 2.04%) are two of the most valuable healthcare stocks in the world, largely due to their successful diabetes and weight loss medications. They are also big
Novo Nordisk Stock Jumps on Upgrade to 'Buy'
09:08am, Wednesday, 08'th Jan 2025
U.S.-listed shares of Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) are up 3.5% premarket, following a bull note from UBS.
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact
07:08am, Wednesday, 08'th Jan 2025
At least four analysts weighed in on the prospects for Europe's second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss drug
Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases
06:30am, Wednesday, 08'th Jan 2025
Bagsværd, Denmark and Lexington, Massachusetts, US, 8 January 2025 – Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop nove
Novo Nordisk Needs Answers to These 5 Key Questions
02:00am, Wednesday, 08'th Jan 2025
Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental obesity pill, and supply capacity for Ozempic and Wegovy.
Novo Nordisk (NVO) Suffers a Larger Drop Than the General Market: Key Insights
06:51pm, Tuesday, 07'th Jan 2025
In the closing of the recent trading day, Novo Nordisk (NVO) stood at $83.34, denoting a -1.99% change from the preceding trading day.
Trump's Danish Tariff Threat Means News Uncertainty for Ozempic Drugmaker Novo Nordisk
03:59pm, Tuesday, 07'th Jan 2025
It's not at all clear what a tariff would mean for Novo, which manufactures its medicines in facilities all over the world, including in the U.S.
Seattle genomics startup Variant Bio signs deal with Novo Nordisk worth up to $50M
01:07pm, Tuesday, 07'th Jan 2025
Variant Bio today announced a partnership with Novo Nordisk for disease research and development that could total $50 million for the biotech startup.
Brokers Suggest Investing in Novo Nordisk (NVO): Read This Before Placing a Bet
10:41am, Tuesday, 07'th Jan 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
